Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 18,943 | 0 |
| Gross Profit | N/A | N/A | N/A | 18,943 | N/A |
| Operating Expenses | 196,919 | 191,089 | -144,648 | 86,897 | 60,335 |
| Operating Income | -196,919 | -191,089 | 144,648 | -67,954 | -60,335 |
| Other Income | 29,461 | 21,866 | 6,668 | 469 | 877 |
| Pre-tax Income | -167,458 | -169,223 | 151,316 | -67,485 | -59,458 |
| Income Tax | 117 | -14,122 | 42,121 | 0 | N/A |
| Net Income Continuous | -167,575 | -155,101 | 109,195 | -67,485 | -59,458 |
| Minority Interests | -192 | -1,939 | -2,019 | -1,915 | -7,659 |
| Net Income | $-167,383 | $-153,162 | $111,214 | $-65,570 | $-51,799 |
| EPS Basic Total Ops | -2.78 | -3.21 | 2.46 | -1.52 | -2.60 |
| EPS Basic Continuous Ops | -3.12 | -3.73 | 2.42 | -1.57 | -2.99 |
| EPS Diluted Total Ops | -2.78 | -3.21 | 2.38 | -1.52 | -2.60 |
| EPS Diluted Continuous Ops | -3.12 | -3.73 | 2.34 | -1.57 | -2.99 |
| EPS Diluted Before Non-Recurring Items | -2.78 | -3.69 | 2.38 | -1.52 | -5.48 |
| EBITDA(a) | $-196,613 | $-190,779 | $144,741 | $-67,901 | $-60,273 |